Hematology Testing

Our team of hematopathologists provide academic-caliber, definitive diagnoses. Miraca Life Sciences believes in responsible assay utilization and only orders those tests that are clinically appropriate for accurate diagnosis. Below is a sampling of tests offered by Miraca Life Sciences.

For full test details and indications, please download our Peripheral Blood test offerings and our Bone Marrow test offerings.


Peripheral Blood Test

Morphology/Microscopic Consult

  • Morphology Evaluation
  • Consult

Flow Cytometry

  • Peripheral Blood Panel
  • ZAP-70 for CLL
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)

Cytogenetics

  • Cytogenetic Analysis Only
  • With reflex to FISH if clinically indicated

Fluorescence In Situ Hybridization (FISH)

Panels include:
  • ALL
  • AML
  • CLL
  • CML
  • Eosinophilia
  • Individual Probes

Molecular

  • BCR/ABL Major (p210) and Minor (p190)
  • BCR/ABL Kinase Domain
  • BCR/ABL T315I Mutation
  • JAK2 V617F
  • cMPL
  • JAK2 Exon 12
  • MPL W515K/L
  • Calreticulin
  • IgVH Mutation Analysis
  • Quantitative PML/RARA
  • AML Prognostic Panel (FLT-3, NPM1, KIT, WT-1, CEBPA)
  • B-Cell Clonality
  • T-Cell Clonality
  • BCL-1
  • BCL-2
  • KIT (D816V) Mutation
  • Other

Back to Top


Bone Marrow test offerings

Morphology/Microscopic Consult

  • Morphology Evaluation
  • Consult

Flow Cytometry

  • Bone Marrow Panel

Cytogenetics

  • Cytogenetic Analysis Only
  • With reflex to FISH if clinically indicated

Fluorescence In Situ Hybridization (FISH)

Panels include:
  • ALL
  • AML
  • CML
  • CLL
  • Eosinophilia
  • MDS
  • MPN
  • MM
  • NHL
  • Individual Probes

Molecular

  • BCR/ABL Major (p210) and Minor (p190)
  • BCR/ABL Kinase Domain
  • BCR/ABL T315I Mutation
  • JAK2 V617F
  • cMPL
  • JAK2 Exon 12
  • MPL W515K/L
  • Calreticulin
  • IgVH Mutation Analysis
  • Quantitative PML/RARA
  • AML Prognostic Panel (FLT-3, NPM1, KIT, WT-1, CEBPA)
  • B-Cell Clonality
  • T-Cell Clonality
  • BCL-1
  • BCL-2
  • KIT (D816V) Mutation
  • Other

Prompt Service,
Better Reports


“Within only a few years, all of our staff physicians were sending 100% of our tissue specimens to Miraca Life Sciences because of their prompt (24-48 hr), high quality, clinically relevant pathology reports.”

– Tom Deas, Jr. MD

Learn More »

We’re pleased with the excellent MU resources that Steve Sharp has provided, and the advocacy he has taken on our behalf. Howard Gervasoni is a true MU SME, helping us to understand the rules and their applicability to us on a pragmatic basis, assisting [with] implementing the compliance mechanics within our practice’s clinical operations, guiding our scorekeeping analytics as we monitored our performance through the measurement periods, testing our IT systems and security as appropriate, and supporting our input submission and validation processes. In addition to technical competence, he has great interpersonal skills—important in helping irritated lay people deal with a perceived “nuisance” endeavor. The “bottom line” is that with Miraca’s help we achieved our MU goals which were of significant consequence to us!
— Morgan Hunnewell, Practice Manager; Ron Drabik, Project Administrator; Dr. Vinod Thakkar, President,
Thakkar, Patel & Avalos, Sebring, Fla.


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.
TRADESHOWS >> FIND posters and presentations from past shows, and see where Miraca Life Sciences will be next.

Meet Our Experts


Raul C. Braylan, MD
Riccardo Valdez, MD

Vice President, Medical Director, Hematopathology

Blood Based Disorders


Learn about Miraca Life Sciences' comprehensive service for blood and bone marrow cancer testing.

learn more